Gautier et al. successfully acquired a preventive effect on development of pathological features in a CMT1A rat model through the local delivery of AAV2/9 expressing shRNAs against PMP22 [113]. The gene discussed is PMP22; the disease is Charcot-Marie-Tooth disease type 1A.